|
1
|
Chiou JF, Tai CJ, Huang MT, Wei PL, Wang
YH, An J, Wu CH, Liu TZ and Chang YJ: Glucose-regulated protein 78
is a novel contributor to acquisition of resistance to sorafenib in
hepatocellular carcinoma. Ann Surg Oncol. 17:603–612. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mazzaferro V, Regalia E, Doci R, Andreola
S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A and
Gennari L: Liver transplantation for the treatment of small
hepatocellular carcinomas in patients with cirrhosis. N Engl J Med.
334:693–699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases, : Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greten TF and Sangro B: Targets for
immunotherapy of liver cancer. J Hepatol. Sep 18–2017.(Epub ahead
of print).
|
|
5
|
Anindo MI and Yaqinuddin A: Insights into
the potential use of microRNAs as biomarker in cancer. Int J Surg.
10:443–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chandrasekaran K, Karolina DS, Sepramaniam
S, Armugam A, Wintour EM, Bertram JF and Jeyaseelan K: Role of
microRNAs in kidney homeostasis and disease. Kidney Int.
81:617–627. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Petrovic N, Ergün S and Isenovic ER:
Levels of MicroRNA heterogeneity in cancer biology. Mol Diagn Ther.
21:511–523. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alhoot MA, Wang SM and Sekaran SD: RNA
interference mediated inhibition of dengue virus multiplication and
entry in HepG2 cells. PLoS One. 7:e340602012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin Y, Wang J, Han J, Luo D and Sun Z:
MiR-122 inhibits epithelial-mesenchymal transition in
hepatocellular carcinoma by targeting Snail1 and Snail2 and
suppressing WNT/β-cadherin signaling pathway. Exp Cell Res.
360:210–217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhong L, Sun S, Shi J, Cao F, Han X and
Chen Z: MicroRNA-125a-5p plays a role as a tumor suppressor in lung
carcinoma cells by directly targeting STAT3. Tumour Biol.
39:10104283176975792017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng H, Wu J, Shi J, Lu C, Wang Y, Sun Q,
Zhang G and Zhao G: miR-125a-5p upregulation suppresses the
proliferation and induces the cell apoptosis of lung adenocarcinoma
by targeting NEDD9. Oncol Rep. 38:1790–1796. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Natalia MA, Alejandro GT, Virginia TJ and
Alvarez-Salas LM: MARK1 is a novel target for miR-125a-5p:
Implications for cell migration in cervical tumor cells. Microrna.
7:54–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cao Y, Tan S, Tu Y, Zhang G, Liu Y, Li D,
Xu S, Le Z, Xiong J, Zou W, et al: MicroRNA-125a-5p inhibits
invasion and metastasis of gastric cancer cells by targeting BRMS1
expression. Oncol Lett. 15:5119–5130. 2018.PubMed/NCBI
|
|
15
|
Li G, Zhang W, Gong L and Huang X:
MicroRNA 125a-5p inhibits cell proliferation and induces apoptosis
in hepatitis B virus-related hepatocellular carcinoma by
downregulation of ErbB3. Oncol Res. 27:449–458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fook-Alves VL, de Oliveira MB, Zanatta DB,
Strauss BE and Colleoni GW: TP53 regulated inhibitor of apoptosis 1
(TRIAP1) stable silencing increases late apoptosis by upregulation
of caspase 9 and APAF1 in RPMI8226 multiple myeloma cell line.
Biochim Biophys Acta. 1862:1105–1110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimada K, Sakamoto Y, Esaki M, Kosuge T,
Morizane C, Ikeda M, Ueno H, Okusaka T, Arai Y and Takayasu K:
Analysis of prognostic factors affecting survival after initial
recurrence and treatment efficacy for recurrence in patients
undergoing potentially curative hepatectomy for hepatocellular
carcinoma. Ann Surg Oncol. 14:2337–2347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao J, Yu W, Hu K, Li M, Chen J and Li Z:
miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT
signaling pathway. Oncol Rep. 37:2513–2521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie F, Yuan Y, Xie L, Ran P, Xiang X,
Huang Q, Qi G, Guo X, Xiao C and Zheng S: miRNA-320a inhibits tumor
proliferation and invasion by targeting c-Myc in human
hepatocellular carcinoma. Onco Targets Ther. 10:885–894. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu HR, Huang RZ, Yu XN, Shi X,
Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Dong L, Janssen HLA, et
al: Microarray expression profiling of microRNAs reveals potential
biomarkers for hepatocellular carcinoma. Tohoku J Exp Med.
245:89–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang T, Thakur A, Chen T, Yang L, Lei G,
Liang Y, Zhang S, Ren H and Chen M: MicroRNA-15a induces cell
apoptosis and inhibits metastasis by targeting BCL2L2 in non-small
cell lung cancer. Tumour Biol. 36:4357–4365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin S, Liu MD, Wu H, Pang P, Wang S, Li
ZN, Sun CF and Liu FY: Overexpression of hsa-miR-125a-5p enhances
proliferation, migration and invasion of head and neck squamous
cell carcinoma cell lines by upregulating C-C chemokine receptor
type 7. Oncol Lett. 15:9703–9710. 2018.PubMed/NCBI
|
|
25
|
Li Y, Tang X, He Q, Yang X, Ren X, Wen X,
Zhang J, Wang Y, Liu N and Ma J: Overexpression of mitochondria
mediator gene TRIAP1 by miR-320b loss is associated with
progression in nasopharyngeal carcinoma. PLoS Genet.
12:e10061832016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tiedt S, Prestel M, Malik R,
Schieferdecker N, Duering M, Kautzky V, Stoycheva I, Böck J,
Northoff BH, Klein M, et al: RNA-Seq identifies circulating
miR-125a-5p, miR-125b-5p, and miR-143-3p as potential biomarkers
for acute ischemic stroke. Circ Res. 121:970–980. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wen Y, Han J, Chen J, Dong J, Xia Y, Liu
J, Jiang Y, Dai J, Lu J, Jin G, et al: Plasma miRNAs as early
biomarkers for detecting hepatocellular carcinoma. Int J Cancer.
137:1679–1690. 2015. View Article : Google Scholar : PubMed/NCBI
|
